Tumor risks and genotypeâphenotypeâproteotype analysis in 358 patients with germline mutations in<i>SDHB</i>and<i>SDHD</i>

Christopher J. Ricketts(National Cancer Institute), Eamonn R. Maher(Aston University), Umasuthan Srirangalingam(University College Hospital), Nicola Bradshaw(Woolmanhill Hospital), Pip Killick(Cancer Research UK), Gail Kirby(University of Birmingham), Fiona MacDonald(Birmingham Women's Hospital), Emma R. Woodward(Royal Manchester Children's Hospital), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Simon Aylwin(King's College Hospital NHS Foundation Trust), Eleanor Rattenberry(Birmingham Women's Hospital), V K Ajith Kumar(Great Ormond Street Hospital), Patrick J. Morrison(Belfast Health and Social Care Trust), Fiona Lalloo(St Mary's Hospital), D. Gareth Evans(Manchester Academic Health Science Centre), V Murday(Woolmanhill Hospital), Steve Ball(Newcastle University), Trevor Cole(Birmingham Women's Hospital), Fiona Douglas(University of Southern California), John Connell(University of Glasgow), Julia Forman, A. Brew Atkinson(University of Ulster), Ruth Armstrong(Addenbrooke's Hospital), Shirley V. Hodgson(St George's, University of London), Tom L. Blundell(University of Cambridge), Shern L. Chew(William Harvey Research Institute), Jackie Cook(Sheffield Children's Hospital)
Human Mutation
October 3, 2009
Cited by 340


Related Papers